INTERQUIM SA
INTERQUIM SA (Peru) holds 20 active US FDA Type II Drug Master Files and 9 inactive, has DMF or CEP filings on record for 23 active ingredients and is linked to 1 FDA-registered manufacturing site. 1 FDA enforcement record is linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “INTERQUIM SA: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/interquim-sa
Overview
INTERQUIM SA is an active pharmaceutical ingredient (API) supplier with 24 active FDA Type II Drug Master Files, covering ARIPIPRAZOLE LAUROXIL; ARIPIPRAZOLE MONOHYDRATE; ARIPIPRAZOLE MONOHYDRATE STERILE; CELECOXIB; CICLOPIROX USP; DEXMEDETOMIDINE HYDROCHLORIDE.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which INTERQUIM SA holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
INTERQUIM SA holds 20 active (29 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- EDARAVONEActive2025-02-26
- ARIPIPRAZOLE LAUROXILActive2024-07-30
- FERRIC CARBOXYMALTOSEActive2024-07-17
- ARIPIPRAZOLE MONOHYDRATE STERILEActive2022-08-02
- LIFITEGRASTActive2022-07-18
- ARIPIPRAZOLE MONOHYDRATEActive2021-03-31
- PALIPERIDONE PALMITATEActive2018-07-26
- PALIPERIDONE PALMITATE STERILEActive2016-04-07
- RIVAROXABANActive2015-01-23
- ROFLUMILASTActive2014-07-31
- CELECOXIBActive2013-02-13
- ROTIGOTINEActive2012-09-26
- OZENOXACINActive2011-06-08
- SOLIFENACIN SUCCINATEActive2010-09-10
- RIVASTIGMINEActive2009-07-22
- IMIQUIMODActive2007-02-07
- TOLTERODINE TARTRATEActive2006-07-14
- CICLOPIROX USPActive2005-11-02
- RISPERIDONEActive2005-04-11
- SERTACONAZOLE NITRATEActive1996-01-09
- PALIPERIDONEInactive2010-11-22
- DARIFENACIN HYDROBROMIDEInactive2009-08-17
- RIVASTIGMINE TARTRATEInactive2009-05-13
- TOLTERODINE TARTRATE MICRONIZEDInactive2006-07-21
- ABAPERIDONE HYDROCHLORIDEInactive2002-12-05
- CITICOLINE MONOSODIM SALTInactive2001-06-18
- SODIUM CITICOLINEInactive1997-10-15
- DOTARIZINEInactive1994-11-23
- MANUFACTURING SITE, FACILITIES, PERSONNEL AND GENERAL OPERATING PROCEDURES IN BARCELONA, SPAINInactive1994-11-23
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to INTERQUIM SA, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
1 FDA enforcement record linked to this company.
- warning_letter2016-11-22
FDA Warning Letter (drug product)
Is this INTERQUIM SA?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.